Home | Sitemap | Search | Contact A- A A+
   
 
    Public Member Support us  
 

IBCSG 27-02 / BIG 1-02 (CALOR) 

A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer

Chemotherapy as Adjuvant for LOcally Recurrent (CALOR)

Chemotherapy vs. observation

DESIGN

Design 27-02

Study Chairs
Prof. Stefan Aebi - Bern, Switzerland
Dr. Irene Wapnir - Stanford, USA

Statistician
Shari Gelber

Trial Coordinators
Holly Shaw

Data Managers
Karolyn Scott

IBCSG Data Management Center/FSTRF
4033 Maple Road
Amherst, New York 14226 USA
Phone: +1 716 834 0900
Fax: +1 716 833 3990
Email: ibcsg27@fstrf.org

Date of Activation
July 31, 2002

Targeted Accrual
977 patients


Other Pathology


News

18.02.2015:
A few impressions from our audits

16.02.2015:
Thank you for your interest in working for IBCSG. Currently we do not have any open positions.

11.02.2015:
Latest SOLE flash

All News

 
  Print